Drug Safety and Pharmacovigilance

Drug safety relates to the potential for adverse effects related to the administration of drugs. Efforts to establish the safely profile of drugs begin early in their development, with in vitro and in vivo toxicity testing, and continue through clinical trials leading up to drug approval and following approval in specific post-marketing studies or general pharmacovigilance efforts
Pharmacovigilance (PV or PhV), also known as drug safety, is the pharmacological science relating to the collection, detection, assessment, monitoring, and prevention of adverse effects with pharmaceutical products.The etymological roots for the word "pharmacovigilance" are: pharmakon (Greek for drug) and vigilare (Latin for to keep watch). As such, pharmacovigilance heavily focuses on adverse drug reactions, or ADRs, which are defined as any response to a drug which is noxious and unintended, including lack of efficacy (the condition that this definition only applies with the doses normally used for the prophylaxis, diagnosis or therapy of disease, or for the modification of physiological disorder function was excluded with the latest amendment of the applicable legislation).Medication errors such as overdose, and misuse and abuse of a drug as well as drug exposure during pregnancy and breastfeeding, are also of interest, even without an adverse event, because they may result in an adverse drug reaction
 

  • Signal Detection in Drug Safety
  • Consulting on Risk Management
  • Adverse Event Reporting
  • Postmarketing Drug Safety

Related Conference of Drug Safety and Pharmacovigilance

December 02-03, 2020

2nd International Conference on Bio-Pharmaceuticals

Auckland, Newzealand
December 07-08, 2020

International Conference on Biotechnology and Healthcare

Auckland, Newzealand
December 16-16, 2020

21st World Conference on Pharmaceutical Chemistry and Drug Design

Singapore City, Singapore
December 16-16, 2020

22nd World Congress on Pharmacology, Nursing and Healthcare

Algeria, Algeria
January 22-23, 2021

1 st Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
January 22-23, 2021

1 st World Congress on Rare Diseases & Orphan Drugs

Prague, Czech Republic
February 26-27, 2021

2nd Annual Congress on Antibiotics and Bacterial Infections

Geneva, Switzerland
March 10-11, 2021

6th Pharmaceutical Chemistry Conference

Paris, France
March 16-17, 2021

14th Global Pharmacovigilance And Clinical Trials Summit

Albufeira, Portugal
April 11-12, 2021

2 nd World Pharma Expo

Tokyo, Japan
April 12-13, 2021

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, Newzealand
April 28-29, 2021

31st Annual European Pharma Congress

London, UK
April 28-29, 2021

14th European Biosimilars Congress

London, UK
May 10-11, 2021

20th Annual Meet on Pharmaceutical Sciences

Yokohama, Japan
May 17-18, 2021

8th European Biopharma Congress

Prague, Czech Republic
May 19-20, 2021

36th World Pharmacology and Therapeutics Forum

Singapore, Singapore
June 07-08, 2021

2rd European Conference on Pharmacovigilance and Drug Safety

Prague, Czech Republic
July 10-11, 2021

2 nd Pharma Expo China

Tokyo, Japan
August 16-17, 2021

Global summit on Cosmetic & Reconstructive Surgery

Tokyo, Japan
August 16-17, 2021

34rd World Congress on Pharmacology

London, UK
October 29-30, 2021

14th World Drug Delivery Summit

Vancouver, Canada
October 29-30, 2021

12th Annual Biomarkers and Clinical Research Congress

Vancouver, Canada

Drug Safety and Pharmacovigilance Conference Speakers

Recommended Sessions

Related Journals

Are you interested in